| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/08/2006 | EP1347743B1 Composition for treatment of inflammatory disorders |
| 03/08/2006 | EP1346221B1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 03/08/2006 | EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same. |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1294389B1 Therapeutical use of sophora flavescens or sophora subprostrata extracts |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1274674B1 Choline derivatives for the treatment of alzheimer's disease |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1257581B1 Compounds related to or derived from gfr alpha 4 and their use |
| 03/08/2006 | EP1244670B1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 03/08/2006 | EP1242411B1 Indole derivatives for the treatment of depression and anxiety |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1206261B1 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP1087781B1 Dietary supplement for supporting cerebrovascular tone |
| 03/08/2006 | EP1044186B1 Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 03/08/2006 | EP0877735B1 Polycyclic compounds |
| 03/08/2006 | EP0800532B1 Improved cyclic crf agonists |
| 03/08/2006 | EP0736029B1 Anticonvulsant pseudofructopyranose sulfamates |
| 03/08/2006 | CN1745175A Active immunization to generate antibodies to soluble A-beta |
| 03/08/2006 | CN1745168A Method for culturing neural stem cells using hepatocyte growth factor |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1744911A NOGO,CASPR,F3,NB-3 for treatment of injury and disease to the central nervous system |
| 03/08/2006 | CN1744908A Amino acid derived prodrugs of propofol, compositions and uses thereof |
| 03/08/2006 | CN1744900A Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1 lambda 6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide |
| 03/08/2006 | CN1744897A Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/08/2006 | CN1743316A 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use |
| 03/08/2006 | CN1743302A Arylpiperazines having 5-hydroxyl-typtamine activity |
| 03/08/2006 | CN1742975A Paerpi pill |
| 03/08/2006 | CN1742968A Medicine for treating vascular dementia and preparing method |
| 03/08/2006 | CN1742949A Chinese medicine composition with functions of reducing blood-pressure, reducing-fat, anti-dizzy and calming wind, its preparing method and use |
| 03/08/2006 | CN1742943A Instant preparation of sealwort and preparation process thereof |
| 03/08/2006 | CN1742941A External medicine formulation for treating anhypnia-depression and technology for making plaster using same |
| 03/08/2006 | CN1742923A Quick-acting medicine for treating headache |
| 03/08/2006 | CN1742905A Epilepsy-treating preparation and new preparation method thereof |
| 03/08/2006 | CN1742862A Guipi preparation and new preparing method therefor |
| 03/08/2006 | CN1742837A Bowel-relaxing preparation and new preparing method |
| 03/08/2006 | CN1742809A Method for preparing xiatianwu injecta |
| 03/08/2006 | CN1742750A Bear-gall dropping pills and preparing method |
| 03/08/2006 | CN1742748A Methy cobalamine dispersion tablet and preparing method |
| 03/08/2006 | CN1742736A Buckthorn extract, its preparing method and use in pharmaceutical process |
| 03/08/2006 | CN1742717A Liquid medicine containing lucidril and preparing method |
| 03/08/2006 | CN1742713A Method for preparing sodium ferulate sterilized raw-material medicine |
| 03/08/2006 | CN1742712A Menantine hydrochloride soft capsule and preparing method |
| 03/08/2006 | CN1742711A Menantine hydrochloride effervescent tablet and preparing method thereof |
| 03/08/2006 | CN1244700C Human acetylcholinesterase isomer protein (AR-ACHE) and its gene coding sequence |
| 03/08/2006 | CN1244694C Yak blood superoxide dismutase preparation method |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244581C Method for producing anticholinergic agent substitute bromide |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244579C Synthesis of 2-oxazolidone derivate by one still process |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244577C 4-phenyl-peiperazinyl,-piperidinyl and -tetrahydropyridyl derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/08/2006 | CN1244563C Dibenzo [b,f] azepine intermediates |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244558C 1,2-hydrindene or indoline derivative |
| 03/08/2006 | CN1244367C Chinese medicine oral liquid for curing epilepsy sickness |
| 03/08/2006 | CN1244327C Thebaic analgesic with controllable release of active content |
| 03/08/2006 | CN1244325C Application of anethole trithione in pharmacy |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009056 Glaucoma; multiple sclerosis |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009051 4-(2-pyridyl) piperazines having 5HT7 receptor agonist activity |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
| 03/07/2006 | US7008955 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists |
| 03/07/2006 | US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/07/2006 | US7008947 Use to treat anxiety, depression, a sleep disorder such as primary insomnia, circadian rhythm sleep disorder, dyssomnia NOS, nightmare disorder, or attention deficit disorder |
| 03/07/2006 | US7008946 CCR5 antagonists useful for treating AIDS |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008940 1,6,7,8-tetrahydro-2,2,4,5-tetramethyl-1-(4-methylphenyl)-2H-furo[3,2-e]indole for example; inhibiting lipoperoxide production (antioxidant); treating restenosis after percutaneous transluminal coronary angioplasty; Alzheimer's disease |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008781 Method of enhancing the biological activity of ligands |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008630 Controlling cell differentiation, cell proliferation; antiinflammatory agents; skin disorders |
| 03/07/2006 | US7008616 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration |
| 03/07/2006 | US7008615 Delivery of anti-migraine compounds through an inhalation route |
| 03/07/2006 | US7008444 Method of controlling body temperature while reducing shivering |
| 03/02/2006 | WO2006024018A2 Compositions for treating nociceptive pain |
| 03/02/2006 | WO2006023865A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | WO2006023852A2 Modulators of muscarinic receptors |
| 03/02/2006 | WO2006023630A2 The use of n-aryl diazaspiracyclic compounds in the treatment of addiction |
| 03/02/2006 | WO2006023590A1 3-ARYLTHIOINDOLE-2-CARBOXAMIDE DERIVATIVES AND ANALOGS THEREOF AS INHIBITORS OF CASEIN KINASE Iϵ |
| 03/02/2006 | WO2006023467A1 3-SUBSTITUTED-5- AND 6-AMINOALKYL INDOLE-2-CARBOXYLIC ACID AMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Iϵ |
| 03/02/2006 | WO2006023462A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 03/02/2006 | WO2006023396A2 Vla-4 antagonists |
| 03/02/2006 | WO2006022543A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006022420A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 03/02/2006 | WO2006022356A1 Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 03/02/2006 | WO2006021565A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2006021564A1 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | WO2006021441A1 Biphenyl-carboxylic acids and derivatives thereof and their use in therapy |
| 03/02/2006 | WO2006021412A2 Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| 03/02/2006 | WO2006002121A3 Compounds and methods for treating seizure and paroxysmal disorders |